Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Tutte le Categorie
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Transaction in Own Shares
Transaction in Own Shares 23 October, 2025 • • • • • • • • • • • • • • • •Shell plc (the ‘Company’) announces that on 23 October, 2025 it purchased the following number of Shares for cancellation.Aggregated information on Shares purchased according to trading venue: Date of purchaseNumber of Shares purchasedHighest price paid Lowest price paid Volume weighted average price paid per shareVenueCurrency23/10/2025313,419 £28.6200£28.1450£28...
Nasdaq GlobeNewswire
23/10/2025
Unibail-Rodamco-Westfield sets CEO succession in 2026
Press releaseUnibail-Rodamco-Westfield sets CEO succession in 2026Vincent Rouget, currently Chief Strategy & Investment Officer and acting as COO Europe, appointed CEO and Chairman of the Management Board as from January 1, 2026 Decision reflects the strong position of the business and positive trajectory under ‘A Platform for Growth’ 2025-28 business plan,established by Jean-Marie Tritant, CEO and Chairman of the Management Board since 2021, who will lead the transition...
Nasdaq GlobeNewswire
23/10/2025
Zymeworks Presents Initial Clinical Data from the Phase 1 trial of ZW191, an…
Preliminary efficacy data, combined with a tolerable safety profile, reinforce the potential of ZW191 in patients with advanced solid tumors, including ovarian, endometrial, and non-small cell lung cancer64% overall response rate in gynecological cancers at doses≥ 6.4mg/kgResponses observed at all doses evaluated at 3.2mg/kg and above demonstrating wide therapeutic index of Zymeworks’ novel antibody-drug conjugate platformDose optimization of ZW191 in ovarian cancer to initiate...
Nasdaq GlobeNewswire
23/10/2025
UNIBAIL-RODAMCO-WESTFIELD Q3-2025 TRADING UPDATE
Press releaseUNIBAIL-RODAMCO-WESTFIELD Q3-2025 TRADING UPDATEUPGRADED GUIDANCE AND FLAGSHIP ASSET ACQUISITIONADVANCING ‘A PLATFORM FOR GROWTH’ 2025–28 PLANSolid operating performance in 9M-2025 Tenant sales up +3.4% 1and footfall up +1.8% MGR uplift of +6.7% on top of indexed passing rents+11.0% increase in signed rent per sqm, showing focus on high value leasesLike-for-like Shopping Centres GRI up +2.4%, consistent with H1-2025 Complete delivery in...
Nasdaq GlobeNewswire
23/10/2025
Sword Group: Acquisition of Full On Net, strengthening its expertise in data…
Sword Group is pleased to announce the acquisition of Full On Net, a technology consulting firm headquartered in Madrid, Spain, recognised for its expertise in data science, artificial intelligence and social network analysis. Founded in 2001, Full On Net has built a strong reputation in the Spanish telecoms and insurance market. Its team of experts brings deep technical knowledge and a culture of agility and innovation that aligns perfectly with Sword Group’s strategic vision. This...
Nasdaq GlobeNewswire
23/10/2025
Amundi: success of the capital increase reserved for employees
Amundi: success of the capital increase reserved for employeesThe capital increase reserved for employees "We Share Amundi" (announced last September) was a success:Almost one employee out of two in the world, and more than two out of three employees in France, participated in this operation which proposed for the ninth consecutive year a subscription of shares with a discount. More than 2,500 employees in 15 countries have subscribed to this capital increase for an amount exceeding…
Nasdaq GlobeNewswire
23/10/2025
Valeo - Q3 2025 Sales
Contacts presse Dora Khosrof | +33 7 61 52 82 75 Caroline De Gezelle | + 33 7 62 44 17
[email protected]
Relations investisseurs Marisa Baldo |
[email protected]
Thierry Lacorre |
[email protected]
[email protected]
Attachment PR - Q3 2025 Sales
Nasdaq GlobeNewswire
23/10/2025
PAREF - FINANCIAL INFORMATION AS AT SEPTEMBER 30, 2025
Financial information as at September 30th, 2025 PAREF continues to manage its portfolio and activities with vigilance PAREF Group's consolidated revenue amounted to €19.7m as at September 30, 2025, down -8% compared to the same period in 2024. This trend reflects in particular: A management activity supported by assets under management, but still…
Actusnews Wire
23/10/2025
Festi hf.: Publication of Q3 2025 results on 30 October 2025 and investor…
Festi will publish the Q3 2025 results on Thursday 30 October after closing of markets. Investor meeting on 31 October at 8:30 GMT. An investor meeting will be held on Friday 31 October 2025, at 8:30 am GMT, at the Company’s headquarters at Dalvegur 10 – 14, Kópavogur. Ásta S. Fjeldsted, CEO of Festi, and Magnús Kr. Ingason, CFO of Festi, will present the results and answer questions.The meeting will be streamed live on the Company’s website where registration for the webcast will also...
Nasdaq GlobeNewswire
23/10/2025
Nexity_PR_Business Activity at 30 September 2025
BUSINESS ACTIVITY AT 30 SEPTEMBER 2025RESERVATIONS ONCE AGAIN DRIVEN BY HOMEBUYERS STRONG GROWTH IN SERVICED PROPERTIESGUIDANCE FOR 2025 CONFIRMEDHousing market undergoing significant changeRetail market down 9% in the first half of the year, reflecting the following:End of the Pinel scheme (reservations by individual investors down 45%)Continued momentum for homebuyers (up 11%)Prevailing supply constraints ahead of upcoming local electionsIn this new market,...
Nasdaq GlobeNewswire
23/10/2025
Frost & Sullivan Recognizes Leading Organizations at the 2025 Best Practices…
"Frost & Sullivan presents Best Practices Recognitions to companies that inspire growth within their industries," said Roger Fristad, Global Senior Director of Transformational Growth at Frost & Sullivan. "These organizations identify emerging trends before they become market standards and develop solutions that drive differentiation and sustainable success." "Frost & Sullivan presents Best Practices Recognitions to companies that inspire growth within their…
PR Newswire
23/10/2025
Sword Group: Q3 2025 Results
Q3 2025 Results Consolidated Revenue: €91.2 m Organic Growth (i): +13.2% EBITDA Margin: 12.1%(i) on a like-for-like basis KEY FIGURESConsolidated revenue for Q3 2025 amounts to €91.2 m, representing a +13.2% increase on a like-for-like basis compared to Q3 2024. The EBITDA margin stands at 12.1 %, representing €11.0 m. As of 30 September 2025, consolidated revenue amounts to €267.0 m, an increase of +12.4% on a like-for-like basis compared to 30 September 2024. The EBITDA margin...
Nasdaq GlobeNewswire
23/10/2025
ROCHE BOBOIS : RESILIENT ACTIVITY IN THE THIRD QUARTER - 9 MONTH REVENUE OF EUR…
RESILIENT ACTIVITY IN THE THIRD QUARTER 9-MONTH REVENUE OF €300M, IN LINE WITH EXPECTATIONS RETAIL SALES FROM DIRECTLY OPERATED STORES UP 2.5% IN Q3 AT CONSTANT CURRENCY Paris, 23 October 2025 ROCHE BOBOIS SA (ISIN: FR0013344173 – Ticker: RBO), the global benchmark in high-end home furnishings and French Art de Vivre, reported Q3 2025 revenue of…
Actusnews Wire
23/10/2025
SAVENCIA: Activity at the end of September 2025
Thursday, October 23, 2025 Press Release: activity at the end of September 2025 Organic revenue growth of 2.8% in a fragile economic context Key figures in € million 30/09/25% of sales30/09/24% of sales% Changes TotalStructureChange & IAS 29Organic Growth Net sales5,033 5,082 -1.0-0.3-4.02.8 - Cheese Products2,861 56.9 2,879 56.7 -0.60.0-1.10.5- Other...
Nasdaq GlobeNewswire
23/10/2025
Oxurion Receives Transparency Notification from Atlas Special Opportunities II…
Leuven, BELGIUM – October 23, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a transparency notification on October 22, 2025, from Atlas Special Opportunities II…
Actusnews Wire
23/10/2025
DON'T NOD : The Lonesome Guild Is Available Today
Paris, October 23, 2025 – DON'T NOD, an independent French studio that creates, develops, and publishes video games, is proud to release The Lonesome Guild today on PC, Xbox Series X|S, and PlayStation 5. Developed by Tiny Bull Studios, The Lonesome Guild is an ARPG all about togetherness in a world shrouded by loneliness…
Actusnews Wire
23/10/2025
World Psoriasis Day 2025: IFPA Calls to Stop the Domino Effect of Psoriasis
IFPA's "Stop the Domino Effect" is urging policymakers, healthcare professionals and the public to recognize psoriasis for what it is: a serious, systemic, and life-changing disease that sets off a chain reaction of serious health conditions — from diabetes and cardiovascular disease to depression. The campaign highlights the urgent need for integrated care, early intervention and equal access to treatment worldwide. The organization calls on health authorities to include psoriasis in…
PR Newswire
23/10/2025
Czech Breakthrough in Medicine: H₂ Global Group Receives Regulatory Approval for…
From Japanese discovery to Czech clinical practice From Japanese discovery to Czech clinical practice The project is based on pioneering research by ProfessorShigeo Ohta, co-founder of H₂ Global Group and widely regarded as thefounding father of therapeutic hydrogen medicine. Professor Ohta personally transferred his European patent (EP 3701956 B1), titled"Prophylactic or Therapeutic Agent for Dementia,"to the Group. "Launching a clinical study that directly builds on...
PR Newswire
23/10/2025
Marie Brizard Wine & Spirits: Q3 2025 revenues
Charenton-le-Pont, 23 October 2025 Q3 2025 revenuesSales down 10.5% 1vs. Q3 2024 Significant decline in the France cluster due to difficult annual commercial negotiations with Off-Trade chainsSlight decline in international sales amid a global market slowdown Nine-month 2025 revenues down 9.2%1 at €127.5m France: continued sharp decline in sales, down 19.3% for the first nine months against a backdrop of...
Nasdaq GlobeNewswire
23/10/2025
Ascendion Recognized as a Global Leader in the ISG Provider Lens® for Generative…
Humans + Agents, Working Better Together: Ascendion's agentic model boosts speed, quality, and trust across engineering. Humans + Agents, Working Better Together:Ascendion's agentic model boosts speed, quality, and trust across engineering. Rising Star to Market Leader:Consecutive ISG honors underscore Ascendion's rapid ascent in AI-powered software engineering. BASKING RIDGE, N.J. , Oct. 23, 2025 /PRNewswire/ -- Ascendion, a leader in AI-powered software engineering,...
PR Newswire
23/10/2025
VINCI: quarterly information at 30 September 2025
QUARTERLY INFORMATION AT 30 SEPTEMBER 2025Revenue in the first nine months of 2025 up almost 4%, including 5% growth in the third quarter Dynamic business levels in Energy Solutions and Concessions Increase in order intake in the third quarter; strong order book2025 guidance confirmed REVENUE AND OTHER KEY INDICATORS First nine months 2025/2024change(in € millions)2025 2024 ActualLike-for-like 1Concessions 9,379...
Nasdaq GlobeNewswire
23/10/2025
MAISONS DU MONDE: Third-Quarter and Nine-Month 2025 Activity
PRESS RELEASENantes, October, 23rd, 2025 3rd quarter and 9-month sales 2025 highlights Transformation yielding results in a volatile market environment, Net sales Q3 2025 +5,9% LfL Growth on Retail and International Retail delivered +8% LfL with Southern Europe confirming its dynamism New concept for shopping center continues to deliver double digit growth, new re-opening in Italy Stabilization of Online and France France sales returned to...
Nasdaq GlobeNewswire
23/10/2025
With Med4Cure, EUROAPI accelerates pharmaceutical innovation at the service of…
Press Release The project launch event, held at the Vertolaye site, brought together State officials, elected representatives, and several project partners to accelerate pharmaceutical innovation in EuropeParis – October 23, 2025– EUROAPI officially launched its innovation programs today as part of the Health IPCEI (Important Project of Common European Interest), a European initiative aimed at strengthening pharmaceutical sovereignty. This project, called “Med4Cure,”...
Nasdaq GlobeNewswire
23/10/2025
Cegedim: like-for-like revenue growth of 2.1% over 9 months is on target
PRESS RELEASEQuarterly financial information as of September 30, 2025 IFRS - Regulated information - Not auditedCegedim: like-for-like revenue growth of 2.1% over 9 months is on targetRevenue of €153.7 million in Q3 2025, up 0.5%Q3 growth engines: cloud, HR, digitalization and health & provident insurance solutions Cumulative 9M 2025 revenue of €476.1 millionBoulogne-Billancourt, France, October 23, 2025, after the market close Revenue ...
Nasdaq GlobeNewswire
23/10/2025
Altri Comunicati